Technical Analysis for TTNP - Titan Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 1.34 -4.96% -0.07
TTNP closed down 4.96 percent on Friday, May 24, 2019, on 62 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical TTNP trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -4.96%
Lower Bollinger Band Walk Weakness -4.96%
Oversold Stochastic Weakness -4.96%
1,2,3 Pullback Bullish Bullish Swing Setup -5.63%

Older signals for TTNP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. Its Probuphine is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment; and utilizes ProNeura, a novel, proprietary, and long-term drug delivery technology. The company's ProNeura is also used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. It is also developing Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. The company was founded in 1992 and is based in South San Francisco, California.
Pharmaceutical Chemical Compounds Organic Compounds Schizophrenia Parkinson's Disease Morphinans Opioids Buprenorphine Drug Rehabilitation Atypical Antipsychotics Fanapt Iloperidone
Is TTNP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.45
52 Week Low 0.172
Average Volume 377,892
200-Day Moving Average 0.9324
50-Day Moving Average 1.6698
20-Day Moving Average 1.593
10-Day Moving Average 1.5091
Average True Range 0.1102
ADX 34.82
+DI 18.2555
-DI 20.3681
Chandelier Exit (Long, 3 ATRs ) 1.8494
Chandelier Exit (Short, 3 ATRs ) 1.6406
Upper Bollinger Band 1.8308
Lower Bollinger Band 1.3552
Percent B (%b) -0.03
BandWidth 29.855618
MACD Line -0.0752
MACD Signal Line -0.0434
MACD Histogram -0.0317
Fundamentals Value
Market Cap 28.41 Million
Num Shares 21.2 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -2.20
Price-to-Sales 259.08
Price-to-Book 6.11
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.53
Resistance 3 (R3) 1.55 1.49 1.50
Resistance 2 (R2) 1.49 1.44 1.49 1.49
Resistance 1 (R1) 1.42 1.41 1.39 1.40 1.48
Pivot Point 1.36 1.36 1.35 1.36 1.36
Support 1 (S1) 1.29 1.31 1.26 1.28 1.20
Support 2 (S2) 1.23 1.28 1.23 1.19
Support 3 (S3) 1.16 1.23 1.18
Support 4 (S4) 1.15